NO148998C - Utgangsmaterialer til bruk for fremstilling av substituerte omega-pentanorprostaglandiner - Google Patents

Utgangsmaterialer til bruk for fremstilling av substituerte omega-pentanorprostaglandiner

Info

Publication number
NO148998C
NO148998C NO743493A NO743493A NO148998C NO 148998 C NO148998 C NO 148998C NO 743493 A NO743493 A NO 743493A NO 743493 A NO743493 A NO 743493A NO 148998 C NO148998 C NO 148998C
Authority
NO
Norway
Prior art keywords
pentanorprostaglandines
preparation
materials used
substituted omega
outstanding materials
Prior art date
Application number
NO743493A
Other languages
English (en)
Other versions
NO148998B (no
NO743493L (no
Inventor
Jasjit Singh Bindra
Michael Ross Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO743493L publication Critical patent/NO743493L/no
Application filed by Pfizer filed Critical Pfizer
Publication of NO148998B publication Critical patent/NO148998B/no
Publication of NO148998C publication Critical patent/NO148998C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
NO743493A 1972-11-08 1974-09-26 Utgangsmaterialer til bruk for fremstilling av substituerte omega-pentanorprostaglandiner NO148998C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (3)

Publication Number Publication Date
NO743493L NO743493L (no) 1974-05-09
NO148998B NO148998B (no) 1983-10-17
NO148998C true NO148998C (no) 1984-01-25

Family

ID=23178133

Family Applications (3)

Application Number Title Priority Date Filing Date
NO4288/73A NO147836C (no) 1972-11-08 1973-11-07 Nye 16-aryloksy-substituerte omega-tetranorprosta-glandiner for anvendelse som fruktbarhetsregulerende middel, svangerskapsavbrytende middel eller middel for synkronisering av brunstcyklusen hos husdyr
NO743493A NO148998C (no) 1972-11-08 1974-09-26 Utgangsmaterialer til bruk for fremstilling av substituerte omega-pentanorprostaglandiner
NO750535A NO149139C (no) 1972-11-08 1975-02-18 Dimetyloksofosfonater for anvendelse som utgangsmateriale ved fremstilling av fysiologisk aktive prostaglandiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO4288/73A NO147836C (no) 1972-11-08 1973-11-07 Nye 16-aryloksy-substituerte omega-tetranorprosta-glandiner for anvendelse som fruktbarhetsregulerende middel, svangerskapsavbrytende middel eller middel for synkronisering av brunstcyklusen hos husdyr

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO750535A NO149139C (no) 1972-11-08 1975-02-18 Dimetyloksofosfonater for anvendelse som utgangsmateriale ved fremstilling av fysiologisk aktive prostaglandiner

Country Status (29)

Country Link
JP (3) JPS5416491B2 (no)
AR (3) AR200585A1 (no)
AT (3) AT367034B (no)
AU (1) AU470375B2 (no)
BE (1) BE806995A (no)
CA (3) CA1085831A (no)
CH (1) CH597176A5 (no)
CS (3) CS182793B2 (no)
DD (4) DD118856A5 (no)
DE (1) DE2355540C2 (no)
DK (1) DK144247C (no)
ES (3) ES420325A1 (no)
FI (1) FI60389C (no)
FR (3) FR2205335B1 (no)
GB (3) GB1456513A (no)
HK (3) HK28179A (no)
HU (3) HU172703B (no)
IE (1) IE39537B1 (no)
IL (1) IL43589A (no)
IN (1) IN139384B (no)
KE (3) KE2931A (no)
MY (3) MY7900245A (no)
NL (1) NL164273C (no)
NO (3) NO147836C (no)
PH (3) PH13272A (no)
SE (4) SE448992B (no)
SU (4) SU584766A3 (no)
YU (3) YU39715B (no)
ZA (1) ZA738554B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
GB1506816A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
ES449162A1 (es) * 1975-06-23 1977-12-16 Syntex Inc Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
GB1516414A (en) * 1975-08-22 1978-07-05 Ici Ltd Prostane derivatives
SE7809008L (sv) * 1977-12-12 1979-06-13 Upjohn Co Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter
DK523378A (da) * 1978-01-16 1979-07-17 Pfizer Fremgangsmaade til fremstilling af n-(tetrazol-5-yl) prostaglandin-carboxamider eller salte deraf
EP1012137B1 (en) * 1997-09-09 2002-11-06 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
HUP0200258A2 (hu) 1999-03-05 2002-05-29 The Procter & Gamble Co. C16-telítetlen FP-szelektív prosztaglandin analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
JP2002329615A (ja) * 2001-05-02 2002-11-15 Ohira Denshi Kk トロイダルコイル
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
US20060135609A1 (en) 2004-10-21 2006-06-22 Duke University Ophthamological drugs
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
CS182791B2 (en) 1978-05-31
FR2205335B1 (no) 1978-07-13
ZA738554B (en) 1974-09-25
NO149139B (no) 1983-11-14
AT353285B (de) 1979-11-12
MY7900246A (en) 1979-12-31
DK144247C (da) 1982-07-12
ATA544576A (de) 1980-06-15
IE39537B1 (en) 1978-11-08
YU36975B (en) 1984-08-31
JPS5416491B2 (no) 1979-06-22
NO147836B (no) 1983-03-14
BE806995A (fr) 1974-05-07
KE2930A (en) 1979-03-30
CA1085831A (en) 1980-09-16
ATA544676A (de) 1979-04-15
JPS5257147A (en) 1977-05-11
GB1456512A (en) 1976-11-24
SU667141A3 (ru) 1979-06-05
PH13110A (en) 1979-11-28
FR2283146B1 (no) 1981-06-19
NO750535L (no) 1974-05-09
NL7315263A (no) 1974-05-10
FR2279729B1 (no) 1978-04-28
GB1456513A (en) 1976-11-24
SE445111B (sv) 1986-06-02
ATA936973A (de) 1981-10-15
DD118856A5 (no) 1976-03-20
PH13272A (en) 1980-02-27
KE2931A (en) 1979-03-30
YU270780A (en) 1982-06-18
SE7700718L (sv) 1977-01-24
AT360672B (de) 1981-01-26
ES420325A1 (es) 1976-04-16
SU745362A3 (ru) 1980-06-30
DK144247B (da) 1982-01-25
HU172703B (hu) 1978-11-28
SE448992B (sv) 1987-03-30
AU6224773A (en) 1975-05-08
FR2205335A1 (no) 1974-05-31
CA1088930A (en) 1980-11-04
AR202931A1 (es) 1975-07-31
CS182793B2 (en) 1978-05-31
IL43589A (en) 1980-01-31
HU173507B (hu) 1979-05-28
YU39715B (en) 1985-04-30
YU288073A (en) 1982-02-28
DE2365322B2 (de) 1977-02-24
HK27979A (en) 1979-05-11
MY7900243A (en) 1979-12-31
PH13325A (en) 1980-03-13
IN139384B (no) 1976-06-12
SE7700716L (sv) 1977-01-24
SE431756B (sv) 1984-02-27
DE2355540C2 (de) 1982-11-18
HK28079A (en) 1979-05-11
SU893130A3 (ru) 1981-12-23
FI60389B (fi) 1981-09-30
AR199966A1 (es) 1974-10-08
SE436278B (sv) 1984-11-26
CA1088931A (en) 1980-11-04
SE7700717L (sv) 1977-01-24
IL43589A0 (en) 1974-03-14
DE2365322A1 (de) 1974-11-07
GB1456514A (en) 1976-11-24
ES433047A1 (es) 1976-11-01
JPS4993342A (no) 1974-09-05
HK28179A (en) 1979-05-11
YU37316B (en) 1984-08-31
NO149139C (no) 1984-02-29
DE2355540A1 (de) 1974-05-22
CS182794B2 (en) 1978-05-31
DD109212A5 (no) 1974-10-20
IE39537L (en) 1974-05-08
NO148998B (no) 1983-10-17
MY7900245A (en) 1979-12-31
AT367034B (de) 1982-05-25
HU171819B (hu) 1978-03-28
YU270680A (en) 1983-04-27
FI60389C (fi) 1982-01-11
AR200585A1 (es) 1974-11-22
NO147836C (no) 1983-06-22
DD117233A5 (no) 1976-01-05
SU584766A3 (ru) 1977-12-15
AU470375B2 (en) 1976-03-11
CH597176A5 (no) 1978-03-31
NL164273C (nl) 1980-12-15
JPS5253841A (en) 1977-04-30
FR2283146A1 (fr) 1976-03-26
ES433046A1 (es) 1977-06-16
FR2279729A1 (fr) 1976-02-20
NO743493L (no) 1974-05-09
DD119411A5 (no) 1976-04-20
KE2932A (en) 1979-03-30

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE401849B (sv) Konstruktionselement for bildande av takrenne - enheter
SE397257B (sv) Forfarande for framstellning av sackaroshaltiga sotningsmedel
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
NO148998C (no) Utgangsmaterialer til bruk for fremstilling av substituerte omega-pentanorprostaglandiner
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
NO139522C (no) Fremgangsmaate til fremstilling av deoksyamino-glycosid-antibiotika
SE414025B (sv) Forfarande for framstellning av fototropa flerfokala glasogonglas
NO139861C (no) Fremgangsmaate til fremstilling av 1-hydroksy-2-pyridoner
SE404525B (sv) Forfarande for framstellning av 4-aminometyl-cyklohexan-karboxylsyra-1
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE391185B (sv) Forfarande for framstellning av eten-butadiensampolymerer
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO136750C (no) Fremgangsm}te for fremstilling av indanderivater
SE380805B (sv) Forfarande for framstellning av oxazoler
NO138563C (no) Fremgangsmaate til fremstilling av alfa-6-deoksytetracykliner
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe
SE7602150L (sv) Mellanprodukter for framstellning av 4a-aryl-trans-dekahydroisokinolin